BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4157347)

  • 1. Comparison of the in vitro activity of BL-P1654 with gentamicin and carbenicillin against Pseudomonas aeruginosa.
    Watanakunakorn C; Bannister T
    Antimicrob Agents Chemother; 1974 Oct; 6(4):471-3. PubMed ID: 4157347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.
    Wald ER; Standiford HC; Tatem BA; Calia FM; Hornick RB
    Antimicrob Agents Chemother; 1975 Mar; 7(3):336-40. PubMed ID: 806263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirbenicillin: comparison with carbenicillin and BL-P1654, alone and with gentamicin, against Pseudomonas aeruginosa.
    Lopez CE; Standiford HC; Tatem BA; Calia FM; Schimpff SC; Snyder MJ; Hornick RB
    Antimicrob Agents Chemother; 1977 Mar; 11(3):441-8. PubMed ID: 404963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity in vitro of ticarcillin, BL-P1654, and carbenicillin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1976 Aug; 10(2):241-4. PubMed ID: 984764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy studies with Pseudomonas aeruginosa resistant to gentamicin and/or carbenicillin.
    Klein RA; Meyer RD
    Chemotherapy; 1978; 24(5):283-9. PubMed ID: 97057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antibiotic efficacy using electron microscopy: morphological effects of guanylureido cephalosporin, chlorobenzoylureido cephalosporin, BL-P1654, and carbenicillin on Pseudomonas aeruginosa.
    Ellis LF; Herron DK; Preston DA; Simmons LK; Schlegel RA
    Antimicrob Agents Chemother; 1976 Feb; 9(2):334-42. PubMed ID: 817659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.
    Kluge RM; Standiford HC; Tatem B; Young VM; Greene WH; Schimpff SC; Calia FM; Hornick RB
    Antimicrob Agents Chemother; 1974 Oct; 6(4):442-6. PubMed ID: 4157342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.
    Anderson EL; Gramling PK; Vestal PR; Farrar WE
    Antimicrob Agents Chemother; 1975 Sep; 8(3):300-4. PubMed ID: 810083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.
    Weinstein RJ; Young LS; Hewitt WL
    J Lab Clin Med; 1975 Nov; 86(5):853-62. PubMed ID: 810533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials.
    Lockwood WR; Lawson LA
    Antimicrob Agents Chemother; 1973 Sep; 4(3):281-4. PubMed ID: 4202342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of gentamicin- and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment.
    Gaman W; Cates C; Snelling CF; Lank B; Ronald AR
    Antimicrob Agents Chemother; 1976 Mar; 9(3):474-80. PubMed ID: 816250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa.
    Sofianou DC; Douboyas JP
    J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B.
    Duncan IB
    Antimicrob Agents Chemother; 1974 Jan; 5(1):9-15. PubMed ID: 4365116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirbenicillin, a new semisynthetic penicillin with broad-spectrum activity.
    Bodey GP; Rodriguez V; Weaver S
    Antimicrob Agents Chemother; 1976 Apr; 9(4):668-74. PubMed ID: 817665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparity between inhibitory and killing effects of BL-P1654.
    Kurtz S; Holmes K; Turck M
    Antimicrob Agents Chemother; 1975 Feb; 7(2):215-8. PubMed ID: 1137373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin.
    Phair JP; Watanakunakorn C; Bannister T
    Appl Microbiol; 1969 Sep; 18(3):303-6. PubMed ID: 4984762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of gentamicin and carbenicillin in a rat model against infections with Pseudomonas aeruginosa resistant to gentamicin or gentamicin and carbenicillin.
    Khakoo RA; Kluge RM
    J Antimicrob Chemother; 1979 Jan; 5(1):53-9. PubMed ID: 104952
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
    Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
    J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
    Marks MI; Hammerberg S; Greenstone G; Silver B
    Antimicrob Agents Chemother; 1976 Sep; 10(3):399-401. PubMed ID: 825026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of Pseudomonas aeruginosa to gentamicin.
    Chadwick P
    Can Med Assoc J; 1973 Oct; 109(7):585-7. PubMed ID: 4200481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.